Health
COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials – BBC Focus Magazine
Scientists at Cambridge say they aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses.
A coronavirus vaccine candidate developed by the University of Cambridge could begin clinical trials in the UK in the autumn.
A £1.9 million funding boost from Innovate UK, the governments innovation agency, has provided support for a collaboration between Cambridge spin-out company DIOSynVax, the University of Cambridge and the University Hospital Southampton NHS Foundation Trust.
The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University…
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General22 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News12 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoWhy the nation needs the Nationals to ditch Net Zero